BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 11554438)

  • 1. Dose dependent pharmacokinetics of theophylline: Michaelis-Menten parameters for its major metabolic pathways.
    Dadashzadeh S; Tajerzaden H
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):77-83. PubMed ID: 11554438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonlinear metabolic disposition of theophylline.
    Dahlqvist R; Billing B; Miners JO; Birkett DJ
    Ther Drug Monit; 1984; 6(3):290-7. PubMed ID: 6506136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-linear elimination processes of theophylline.
    Gundert-Remy U; Hildebrandt R; Hengen N; Weber E
    Eur J Clin Pharmacol; 1983; 24(1):71-8. PubMed ID: 6832205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear theophylline elimination.
    Tang-Liu DD; Williams RL; Riegelman S
    Clin Pharmacol Ther; 1982 Mar; 31(3):358-69. PubMed ID: 7060318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lansoprazole on pharmacokinetics and metabolism of theophylline.
    Kokufu T; Ihara N; Sugioka N; Koyama H; Ohta T; Mori S; Nakajima K
    Eur J Clin Pharmacol; 1995; 48(5):391-5. PubMed ID: 8641328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.
    Chae JW; An JH; Kang W; Ma Jy; Kwon KI
    Food Chem Toxicol; 2012 Oct; 50(10):3666-72. PubMed ID: 22771369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
    Choi HD; Kang HE; Chung HJ; Bae SK; Shin KN; Lee MG
    Biopharm Drug Dispos; 2007 Nov; 28(8):445-54. PubMed ID: 17847127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear renal excretion of theophylline and its metabolites, 1-methyluric acid and 1,3-dimethyluric acid, in rats.
    Kuh HJ; Shim CK
    Arch Pharm Res; 1994 Apr; 17(2):124-30. PubMed ID: 10319144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theophylline steady state pharmacokinetics is not altered by omeprazole.
    Taburet AM; Geneve J; Bocquentin M; Simoneau G; Caulin C; Singlas E
    Eur J Clin Pharmacol; 1992; 42(3):343-5. PubMed ID: 1577056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theophylline pharmacokinetics and metabolism in rabbits following single and repeated administration of Capsicum fruit.
    Bouraoui A; Brazier JL; Zouaghi H; Rousseau M
    Eur J Drug Metab Pharmacokinet; 1995; 20(3):173-8. PubMed ID: 8751037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new chemoprotective agent, 2-(allylthio)pyrazine, on the pharmacokinetics of intravenous theophylline in rats.
    Han KS; Lee MG
    Int J Pharm; 1999 Jul; 184(2):237-42. PubMed ID: 10387953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats.
    Chae JW; Baek IH; Kwon KI
    J Ethnopharmacol; 2012 Nov; 144(2):248-54. PubMed ID: 22981724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluconazole on theophylline disposition in humans.
    Konishi H; Morita K; Yamaji A
    Eur J Clin Pharmacol; 1994; 46(4):309-12. PubMed ID: 7957514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of theophylline metabolite assays to the exploration of liver microsome oxidative function in man.
    Naline E; Sanceaume M; Pays M; Advenier C
    Fundam Clin Pharmacol; 1988; 2(4):341-51. PubMed ID: 3265407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of CYP inducers and inhibitors on the pharmacokinetics of intravenous theophylline in rats: involvement of CYP1A1/2 in the formation of 1,3-DMU.
    Yang KH; Lee JH; Lee MG
    J Pharm Pharmacol; 2008 Jan; 60(1):45-53. PubMed ID: 18088504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem and cimetidine on theophylline oxidative metabolism.
    Ohashi K; Sakamoto K; Sudo T; Tateishi T; Fujimura A; Shiga T; Ebihara A
    J Clin Pharmacol; 1993 Dec; 33(12):1233-7. PubMed ID: 8126258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theophylline metabolism in human liver microsomes: inhibition studies.
    Tjia JF; Colbert J; Back DJ
    J Pharmacol Exp Ther; 1996 Mar; 276(3):912-7. PubMed ID: 8786569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline and its metabolites produce a stimulating cholinergic effect on the small intestine and a nonadrenergic noncholinergic relaxing effect on the colon: a comparative study in the rabbit intestine.
    Psarra TA; Batzias GC; Peeters TL; Koutsoviti-Papadopoulou M
    J Vet Pharmacol Ther; 2007 Dec; 30(6):541-9. PubMed ID: 17991222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline metabolites in 8 Chinese patients.
    Cao W; Zhuo HT; Chen G; Ling SS
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):437-9. PubMed ID: 10375804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of theophylline: a dose-range study.
    Rovei V; Chanoine F; Strolin Benedetti M
    Br J Clin Pharmacol; 1982 Dec; 14(6):769-78. PubMed ID: 7150456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.